<DOC>
	<DOCNO>NCT00601432</DOCNO>
	<brief_summary>The main purpose study evaluate effect food single-dose pharmacokinetics oral solution levofloxacin .</brief_summary>
	<brief_title>A Study Evaluate Effect Food Levofloxacin Pharmacokinetics From Oral Solution Formulation</brief_title>
	<detailed_description>In single-dose study conduct single center , effect food pharmacokinetics levofloxacin studied 24 healthy men woman age 18 55 year old . Subjects assign different treatment base chance ; researcher study participant knew treatment administer . The study consist 3 phase : screening phase , open-label treatment phase consist 2 treatment period , post-treatment phase . Subjects meet prestudy eligibility criterion randomly assign 1 2 treatment sequence group . In treatment period , subject admit study facility even study drug administration house 48 hour dose study drug . Subjects receive levofloxacin single oral dose 500 mg fed ( within 10 minute completion high-fat , high-caloric breakfast ) fast ( 10-hour overnight fast ) condition accord randomize treatment sequence . Each dose day separate washout period least 4 day . In treatment period , pharmacokinetic blood sample collect immediately prior dose 0.25 , 0.5 , 0.75 , 1 , 1.5 , 2 , 4 , 6 , 10 , 14 , 24 , 30 , 36 , 48 hour dose determination plasma concentration levofloxacin . Safety evaluation , include adverse event monitoring , standard clinical laboratory evaluation ( hematology , serum chemistry , urinalysis ) , vital sign monitoring , physical examination perform Days 1 3 treatment period . The post-treatment phase consist safety evaluation perform collection final pharmacokinetic blood sample second treatment period . Adverse event monitor time first study-related procedure completion post-treatment study procedure , time early withdrawal study . Levofloxacin solution administer 2 single oral dos 500 mg , 1 treatment period , administer least 4 day apart .</detailed_description>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Men woman Aged 18 55 year BMI 18 30 kg/m2 No prescription overthecounter medication previous 14 day Negative test drug alcohol abuse HIV , hepatitis B hepatitis C Healthy base medical history , physical examination , 12lead electrocardiogram , toxicology , antigen , antibody screen , clinical laboratory evaluation Allergic reaction quinolones clinically significant ECG clinical laboratory abnormality creatinine clearance &lt; =80 mL/min acute illness within 7 day receipt experimental drug device within 60 day pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>open-label</keyword>
	<keyword>randomize</keyword>
	<keyword>crossover</keyword>
	<keyword>food effect</keyword>
</DOC>